Search

Dopant‐free hole transport layers (HTLs) play a crucial role in achieving high‐efficiency and stable perovskite solar cells (PSCs). However, only a limited number of these HTLs have demonstrated power conversion efficiencies (PCEs) surpassing 21%. Herein, the design and synthesis of two polymeric HTLs with a novel DA'D–A backbone are presented. The incorporation of two A units (benzothiazole and imide functionalized aromatics) in the polymer imparts a rigid backbone, high mobility, appropriate film morphology, excellent thermal stability, and a deeper highest occupied molecular orbital energy level, crucial for achieving a more suitable energy‐level alignment between HTL and perovskite layer. Notably, the champion PSC based on our HTLs exhibits a remarkable PCE of 22.02% with minimal hysteresis and excellent thermal stability, surpassing the performance of devices based on the benchmark polymeric HTL PTAA under identical conditions. These findings underscore the immense potential of our DA'D‐A backbone strategy in developing high‐performance dopant‐free polymer HTLs for enhancing the PCE of PSCs. [ABSTRACT FROM AUTHOR]

Comprehensive Summary: All‐polymer solar cells (all‐PSCs) have attracted considerable attention due to their inherent advantages over other types of organic solar cells, including superior optical and thermal stability, as well as exceptional mechanical durability. Recently, all‐PSCs have experienced remarkable advancements in device performance thanks to the invention of polymerized small‐molecule acceptors (PSMAs) since 2017. Among these PSMAs, PY‐IT has garnered immense interest from the scientific community due to its exceptional performance in all‐PSCs. In this review, we presented the design principles of PY‐IT and discussed the various strategies employed in device engineering for PY‐IT‐based all‐PSCs. These strategies include additive and interface engineering, layer‐by‐layer processing methods, meniscus‐assisted coating methods, and ternary strategy. Furthermore, this review highlighted several novel polymeric donor materials that are paired with PY‐IT to achieve efficient all‐PSCs. Lastly, we summarized the inspiring strategies for further advancing all‐PSCs based on PY‐IT. These strategies aim to enhance the overall performance and stability of all‐PSCs by exploring new materials, optimizing device architectures, and improving fabrication techniques. By leveraging these approaches, we anticipate significant progress in the development of all‐PSCs and their potential as a viable renewable energy source. [ABSTRACT FROM AUTHOR]

Comprehensive Summary: All‐polymer solar cells (all‐PSCs) have attracted considerable attention due to their inherent advantages over other types of organic solar cells, including superior optical and thermal stability, as well as exceptional mechanical durability. Recently, all‐PSCs have experienced remarkable advancements in device performance thanks to the invention of polymerized small‐molecule acceptors (PSMAs) since 2017. Among these PSMAs, PY‐IT has garnered immense interest from the scientific community due to its exceptional performance in all‐PSCs. In this review, we presented the design principles of PY‐IT and discussed the various strategies employed in device engineering for PY‐IT‐based all‐PSCs. These strategies include additive and interface engineering, layer‐by‐layer processing methods, meniscus‐assisted coating methods, and ternary strategy. Furthermore, this review highlighted several novel polymeric donor materials that are paired with PY‐IT to achieve efficient all‐PSCs. Lastly, we summarized the inspiring strategies for further advancing all‐PSCs based on PY‐IT. These strategies aim to enhance the overall performance and stability of all‐PSCs by exploring new materials, optimizing device architectures, and improving fabrication techniques. By leveraging these approaches, we anticipate significant progress in the development of all‐PSCs and their potential as a viable renewable energy source. [ABSTRACT FROM AUTHOR]

Spontaneous intracerebral haemorrhage (ICH) is the main presentation in adults with moyamoya disease (MMD), an unusual clinical entity with a poor prognosis. However, optimal management in the acute stage of ICH in patients with MMD remains a challenge. Since minimally invasive surgery (MIS) plus local thrombolysis has emerged as a promising strategy for ICH, we aimed to describe our experience of performing this procedure in this special population in the acute phase, while focusing on its efficacy and safety. The medical data of patients with ICH treated with MIS and local thrombolysis between November 2013 and December 2017 were retrospectively reviewed at our institution. MMD was identified based on the angiographic images. The primary outcome was postoperative intracranial rebleeding. The secondary outcomes were 30-day mortality and 6-month outcome graded using the modified Rankin scale (mRS). Logistic regression was applied to explore independent risk factors for the above outcomes. A cohort of consecutive 337 ICH patients was analysed, of whom 14 (4.15%) were diagnosed with MMD. In total, 36 (11.46%) patients experienced postoperative intracranial rehaemorrhage, of which one patient had MMD. No significant difference was found between the patients with and without MMD regarding postoperative rebleeding (9.09% vs. 11.55%, p = 1.000). Additionally, the 30-day mortality of patients with MMD was 21.42% (3/14), which was not significantly different from that of non-MMD patients (10.83%; p = 0.201). Moreover, 53.8% of patients had poor outcomes at the 6-month follow-up among MMD patients, similar to 43.9% of patients without MMD (p = 0.573). The coexistence of MMD failed to show a significant association with postoperative intracranial rebleeding (p = 0.348), 30-day mortality (p = 0.211), or poor outcome at the 6-month follow-up (p = 0.450). Our findings suggest that coexistent MMD is not associated with an increased risk of postoperative rebleeding or poor outcome after local thrombolysis for ICH. [ABSTRACT FROM AUTHOR]

Polymerized small molecule acceptors have recently greatly facilitated the development of all‐polymer solar cells (All‐PSCs) with respect to the power conversion efficiencies (PCEs). However, high‐performance and low‐cost polymer donors for All‐PSCs are still lacking, limiting further large‐scale manufacturing of All‐PSCs. Herein, this work designs and synthesizes a new thiophene derivative, FETVT, featuring vinyl‐bridged fluorine and ester‐substituted monothiophene. Incorporation of FETVT into a polymer yields a high‐performance polythiophene derivative PFETVT‐T, which exhibits deep‐lying HOMO level, suitable solution pre‐aggregation ability, finely‐tuned polymer crystallinity, and appropriate thermodynamic miscibility with the polymer acceptor L15. As a result, binary based on PFETVT‐T achieves a record PCE of 11.81% with agood stability, representing a breakthrough for polythiophenes and their derivatives‐based All‐PSCs, which is also significantly higher than that (1.92%) of All‐PSCs based on its isomerized analog. Remarkably, PFETVT‐T achieves an impressive PCE exceeding 16% via the implementation of a ternary blend design. These findings offer a hopeful pathway toward attaining high‐performance, stable, and cost‐effective PSCs. [ABSTRACT FROM AUTHOR]

The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Omicron variant is undergoing continuous evolution and convergent mutation. These new subvariants are raising concerns that they may evade neutralizing monoclonal antibodies (mAbs). We investigated the serum neutralization efficacy of Evusheld (cilgavimab and tixagevimab) against SARS‐CoV‐2 Omicron BA.2, BA.2.75, BA.2.76, BA.5, BF.7, BQ.1.1, and XBB.1.5. A total of 90 serum samples from healthy individuals were collected in Shanghai. Anti‐RBD antibodies were measured and symptoms of infection with COVID‐19 were compared among those individuals. The neutralizing activity of serum against Omicron variants was analyzed by pseudovirus neutralization assays in 22 samples. Evusheld retained neutralizing activity against BA.2, BA.2.75, and BA.5, albeit with somewhat reduced titers. However, the neutralizing activity of Evusheld against BA.2.76, BF.7, BQ.1.1, and XBB.1.5 significantly decreased, with XBB.1.5 showing the greatest escape activity among the subvariants. We also observed that Evusheld recipients displayed elevated antibody levels in their serum, which efficiently neutralized the original variant, and exhibited different characteristics of infection than those who did not receive Evusheld. The mAb has partial neutralization activity against Omicron sublineages. However, the increasing doses of mAb and a larger size of population should be further investigated. [ABSTRACT FROM AUTHOR]

Simultaneous spontaneous bilateral external capsule hemorrhage is a rare clinical entity with extremely poor outcome. However, knowledge on the effective management of this fatal disease is limited. Herein,we described a case of a 42-year-old man with acute coma and quadriplegia as well as respiratory failure related to the disease. The patient underwent minimally invasive surgery plus local thrombolysis. Consequently, he recovered with satisfactory neurological function recovery on the 180th day of follow-up. [ABSTRACT FROM AUTHOR]

The strain of Zika virus (ZIKV) that circulated during the 2015 epidemic in Brazil has been associated with more than 2000 cases of microcephaly from September 2015 through November 2016. The viral genome determines the biology and pathogenesis of a virus and the virus employs its own gene products to evade host immune surveillance, manipulate cellular machineries, and establish efficient replication. Therefore, understanding the functions of virus‐encoded protein not only aids the knowledge of ZIKV biology but also guides the development of anti‐ZIKV drugs. In this review, we focus on 10 proteins encoded by ZIKV and summarize their functions in ZIKV replication and pathogenesis according to studies published in the past 6 years. [ABSTRACT FROM AUTHOR]

Target based molecular design via the aid of computation is one of the most efficient methods in the discovery of novel pesticides. Here, a combination of the comparative molecular field analysis (CoMFA) and molecular docking was applied for discovery of potent fungicidal [1,2,4]-triazolo-[3,4- b ][1,3,4]-thiadiazoles. Bioassay results indicated that the synthesized target compounds 3a , 3b , and 3c exhibited good activity against Alternaria solani , Botrytis cinerea , Cercospora arachidicola , Fusarium graminearum , Physalospora piricola , Rhizoctonia solani , and Sclerotinia sclerotiorum with an EC 50 value falling between 0.64 and 16.10 μg/mL. Specially, 3c displayed excellent fungicidal activity against C. arachidicola and R. solani, which was 5 times more potent than the lead YZK-C22 . The enzymatic inhibition assay and fluorescence quenching analysis with R. solani pyruvate kinase (RsPK) showed a weaker binding affinity between RsPK and 3a , 3b , or 3c . Transcriptomic analyses showed that 3c exerted its fungicidal activity by disrupting steroid biosynthesis and ribosome biogenesis in eukaryotes. These findings support that 3c is a promising fungicide candidate, and a fine modification from a lead may lead to a totally different mode of action.

Zika virus (ZIKV) is linked to congenital defects including microcephaly. An infection model that can recapitulate most microcephaly-related phenotypes is crucial for understanding ZIKV pathogenesis. Here, we present a protocol to generate ZIKV from an infectious clone through a reverse genetic system and subsequently perform embryonic brain infection with the rescued ZIKV in pregnant mice. We optimized several aspects of the procedures including virus rescue and in utero injection. This protocol facilitates reproducible investigation of virus-induced cortical development defects. For complete details on the use and execution of this protocol, please refer to Zeng et al. (2020)., Competing Interests: The authors declare no competing interests., (© 2021 The Author(s).)

The purpose of this study was to optimize the preparation method of injectable Octreotide microspheres. To explore the correlation between the solvent system and the general properties of microspheres to reduce burst release and enable them to be used for portal hypertension. Octreotide microspheres were prepared by modified double emulsion solution evaporation method after optimizing preparation conditions. The results showed that Octreotide microspheres had a particle size of 57.48 ± 15.24 μm, and the initial release was significantly reduced. In vitro release and in vivo pharmacokinetic data indicated that Octreotide was released stably within 1200 h. The effects on portal vein pressure, liver tissue morphology and other related indexes were observed after administration. As obvious results, injection of Octreotide microspheres could significantly reduce portal vein pressure and reduce the portal vein lumen area in experimental cirrhotic portal hypertensive rats. The optimized Octreotide PLGA microsphere preparation has been proved to have a good effect on PHT in vivo after detecting aminotransferase (AST) and alanine aminotransferase (ALT) activity, liver tissue hydroxyproline (Hyp) content, serum and liver tissue malondialdehyde (MDA) levels, plasma prostacyclin (PGI 2 ) levels, and liver tissue tumor necrosis factor (TNFα) content. In addition, serum and liver tissue superoxide dismutase (SOD) activity and liver tissue glutathione (GSH) content, plasma thromboxane (TXA 2 ), serum nitric oxide (NO), liver tissue nitric oxide synthase (NOS), and plasma and liver tissue endothelin (ET) were significantly increased.